Phospho-HER4/ErbB4 (Tyr1284)/EGFR (Tyr1173) Antibody (Rabbit mAb) [D10B7]

CatNo: F0397

    Application: Reactivity:
    • Lane 1: COS (ERBB4 KD), Lane 2: COS
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    Application
    WB
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    147 kDa
    ポジティブコントロール COS-7 ErbB4 KD cells; A431 + EGF cells; MCF7 + Heregulin (HRG) cells
    ネガティブコントロール COS-7 + EGFR cells; MCF7 (unstimulated) cells; CHO/IR/IRS-1 cells; NIH/3T3 + PDGFR cells; Sf9 cells; MEFs + CSF-1R cells; NR6 cells; COS-7 + FGFR1 cells; Tie2 (cytoplasmic) cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-HER4/ErbB4 (Tyr1284)/EGFR (Tyr1173) Antibody (Rabbit mAb) [D10B7] detects endogenous levels of HER4/ErbB4 protein only when phosphorylated on Tyr1284 and EGFR only when phosphorylated on Tyr1173.
    タンパク質の局在
    細胞膜、細胞内膜系、ミトコンドリア、細胞核
    Uniprot ID
    Q15303
    Clone
    D10B7
    Synonym(s)
    4ICD; ALS19; E4ICD; erb-b2 receptor tyrosine kinase 4; ERBB4; ERBB4 intracellular domain; HER4; human epidermal growth factor receptor 4; MGC138404; p180erbB4; s80HER4
    Background
    Phosphorylated HER4/ErbB4 at Tyr1284 and phosphorylated EGFR at Tyr1173 are activation‑dependent epitopes within the cytoplasmic tails of two HER/ErbB family receptor tyrosine kinases, marking ligand‑induced signaling states that integrate extracellular growth factor cues into intracellular cascades controlling proliferation, survival, and differentiation. Both receptors share a modular architecture with an extracellular ligand‑binding domain, a single transmembrane segment, an intracellular tyrosine kinase domain, and a C‑terminal tail containing multiple tyrosine residues that become autophosphorylated upon receptor dimerization, and Tyr1173 in EGFR and Tyr1284 in ErbB4 reside within this tail as key sites for docking of downstream effectors. Upon binding EGF‑family ligands, EGFR transitions from a monomer to active homo‑ or heterodimers (for example with HER2), which stimulates its intrinsic kinase activity and leads to autophosphorylation of several C‑terminal tyrosines, including Tyr1173; the phosphorylated tail recruits adaptor proteins such as Shc and Grb2 that contain SH2 or PTB domains, thereby initiating major downstream pathways including Ras–Raf–MEK–ERK, PI3K–AKT, PLCγ–PKC, and STAT signaling modules that collectively modulate cell migration, adhesion, proliferation, and survival. Phosphorylation at Tyr1173 functions as a prominent docking site for Shc and other adaptors, coordinating assembly of signaling complexes at the receptor and supporting propagation of mitogenic signals, while endocytosis and dephosphorylation by phosphatases provide feedback that attenuates signaling and reset receptor responsiveness. HER4/ErbB4, activated by neuregulins and several EGF‑family ligands, forms homo‑ and heterodimers with other ErbB members, and ligand binding triggers autophosphorylation at multiple tyrosines including Tyr1284, which serve as binding sites for scaffold proteins and effectors that connect the receptor to MAPK and PI3K–AKT pathways, reorganization of the actin cytoskeleton, and cell migration. Specific ErbB4 isoforms containing cytoplasmic sequences compatible with PI3K recruitment use phosphorylated tail tyrosines to bind the p85 regulatory subunit of PI3K, promoting AKT activation and protection from apoptosis, whereas isoforms lacking these motifs or differing in juxtamembrane processing show reduced coupling to PI3K and instead favor alternative signaling outputs, illustrating how the pattern of tail phosphotyrosines, including Tyr1284, shapes receptor‑specific pathway engagement. Proteolytic processing of ErbB4 can release intracellular domains that translocate to the nucleus or mitochondria, where they interact with transcription factors such as STAT5A at promoters like CSN2 to regulate gene expression or engage mitochondrial pathways that influence apoptosis, and phosphorylation of cytoplasmic tail residues in the full‑length receptor precedes and modulates these cleavage‑dependent functions. In developmental and physiological contexts, ErbB4 signaling through its phosphotyrosine sites is required for cardiac muscle differentiation, central nervous system development, and mammary gland differentiation and lactation, while EGFR signaling through Tyr1173 and other sites contributes to epithelial growth, regeneration, and normal tissue homeostasis. In disease settings, aberrant activation and sustained phosphorylation of EGFR Tyr1173 are implicated in oncogenic signaling and cancer progression, driving excessive mitogenic and survival pathway activity, and altered ErbB4 expression or phosphorylation patterns are associated with multiple carcinomas and neuropsychiatric disorders, where changes in ligand responsiveness, dimerization partners, and tail phosphotyrosine combinations can reprogram transcriptional outputs and cell fate decisions.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください